{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T21:30:34Z","timestamp":1792963834480,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.lungcan.2014.11.006","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T16:30:33Z","timestamp":1416241833000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pemetrexed in patients with thymic malignancies previously treated with chemotherapy"],"prefix":"10.1016","volume":"87","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhmani K.","family":"Padda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel W.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Wakelee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2014.11.006_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0010","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma. A clinicopathologic review","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0003-4975(91)90999-7","article-title":"Maxwell Chamberlain Memorial Paper Role of staging in prognosis and management of thymoma","volume":"51","author":"Wilkins","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s003300050525","article-title":"Mediastinal masses: diagnostic approach","volume":"8","author":"Laurent","year":"1998","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0030","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0035","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0040","first-page":"7079","article-title":"A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma","volume":"24","author":"Loehrer","year":"2006","journal-title":"ASCO Annu Meet Proc"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bjc.6603321","article-title":"A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours","volume":"95","author":"Nakagawa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0050","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0055","series-title":"NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas. Version 1","author":"Ettinger","year":"2014"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma. A 13-year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0070","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0075","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/COC.0b013e318209a8f8","article-title":"Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial","volume":"35","author":"Longo","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0090","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0095","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0100","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0110","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/JTO.0b013e3182208ea8","article-title":"Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy","volume":"6","author":"Sun","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1078-0432.CCR-07-1513","article-title":"Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors","volume":"14","author":"Ceppi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3892\/etm.2012.641","article-title":"Expression of thymidylate synthase and orotate phosphoribosyltransferase in thymic carcinoma","volume":"4","author":"Yokota","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0125","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/JTO.0b013e318183af9c","article-title":"S-1 treatment for chemorefractory thymic carcinoma","volume":"3","author":"Ono","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lungcan.2010.09.004","article-title":"S-1 is an active anticancer agent for advanced thymic carcinoma","volume":"70","author":"Okuma","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.11.006_bib0135","first-page":"299","article-title":"Successful S-1 monotherapy for chemorefractory thymic carcinoma","volume":"31","author":"Koizumi","year":"2011","journal-title":"Anticancer Res"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214004577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214004577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T13:37:45Z","timestamp":1566049065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500214004577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0169500214004577"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.11.006","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemetrexed in patients with thymic malignancies previously treated with chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}